Showing results 1 to 1 of 1
Issue Date | Title | Journal Title |
---|---|---|
2022 | Nivolumab (NIVO) plus chemotherapy (chemo) vs chemo in patients (pts) with EGFR-mutated metastatic non-small cell lung cancer (mNSCLC) with disease progression after EGFR tyrosine kinase inhibitors (TKIs) in CheckMate 722 | ANNALS OF ONCOLOGY |